12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks experienced significant price movements. Ensysce Biosciences, AtriCure, CalciMedica, Matinas BioPharma, Cue Biopharma, and HOOKIPA Pharma saw notable gains, while Applied DNA Sciences, AnaptysBio, Spero Therapeutics, GlycoMimetics, Tempest Therapeutics, and CVRx experienced declines.
October 30, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
AnaptysBio's stock decreased by 21.43% in pre-market trading.
The pre-market decline suggests negative investor sentiment or news, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Applied DNA Sciences' stock fell by 42.2% in pre-market trading, indicating significant negative sentiment.
The significant pre-market price drop suggests negative sentiment or news, likely leading to short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
CVRx's stock fell by 11.92% following the release of its Q3 earnings.
The stock's decline is directly linked to the Q3 earnings report, indicating negative market reaction.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
GlycoMimetics' stock declined by 15.94% in pre-market trading.
The pre-market decline suggests negative investor sentiment or news, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Spero Therapeutics' stock fell by 19.12% in pre-market trading.
The pre-market decline suggests negative investor sentiment or news, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Tempest Therapeutics' stock declined by 14.13% in pre-market trading.
The pre-market decline suggests negative investor sentiment or news, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
AtriCure's stock rose by 18.92% following the release of its Q3 earnings.
The stock's rise is directly linked to the Q3 earnings report, indicating positive market reaction.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
CalciMedica's stock increased by 18.32% in pre-market trading.
The pre-market gain suggests positive investor sentiment or news, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Cue Biopharma's stock rose by 15.38% in pre-market trading.
The pre-market gain suggests positive investor sentiment or news, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Ensysce Biosciences' stock surged by 21.4% in pre-market trading, indicating strong investor interest.
The significant pre-market price increase suggests positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
HOOKIPA Pharma's stock rose by 14.47% in pre-market trading.
The pre-market gain suggests positive investor sentiment or news, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Matinas BioPharma's stock moved up by 18.27% in pre-market trading.
The pre-market gain suggests positive investor sentiment or news, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70